NCT03564132View on ClinicalTrials.gov

Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 16, 2018

Primary Completion Date

August 15, 2020

Study Completion Date

August 31, 2022

Conditions
Tourette DisorderTic Disorders
Interventions
DRUG

Yigansan

Yigansan granules

DRUG

Placebo

One-tenth concentration of Yigansan manufactured to mimic Yigansan granules

Trial Locations (1)

404

China Medical University Hospital, Taichung

All Listed Sponsors
lead

China Medical University Hospital

OTHER

NCT03564132 - Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder | Biotech Hunter | Biotech Hunter